353 related articles for article (PubMed ID: 31869418)
1. Ibrutinib, but not zanubrutinib, induces platelet receptor shedding of GPIb-IX-V complex and integrin αIIbβ3 in mice and humans.
Dobie G; Kuriri FA; Omar MMA; Alanazi F; Gazwani AM; Tang CPS; Sze DM; Handunnetti SM; Tam C; Jackson DE
Blood Adv; 2019 Dec; 3(24):4298-4311. PubMed ID: 31869418
[TBL] [Abstract][Full Text] [Related]
2. Bruton's Tyrosine Kinase Inhibitors Impair FcγRIIA-Driven Platelet Responses to Bacteria in Chronic Lymphocytic Leukemia.
Naylor-Adamson L; Chacko AR; Booth Z; Caserta S; Jarvis J; Khan S; Hart SP; Rivero F; Allsup DJ; Arman M
Front Immunol; 2021; 12():766272. PubMed ID: 34912339
[TBL] [Abstract][Full Text] [Related]
3. Controlled shedding of platelet glycoprotein (GP)VI and GPIb-IX-V by ADAM family metalloproteinases.
Gardiner EE; Karunakaran D; Shen Y; Arthur JF; Andrews RK; Berndt MC
J Thromb Haemost; 2007 Jul; 5(7):1530-7. PubMed ID: 17445093
[TBL] [Abstract][Full Text] [Related]
4. Ibrutinib Inhibits Platelet Integrin αIIbβ3 Outside-In Signaling and Thrombus Stability But Not Adhesion to Collagen.
Bye AP; Unsworth AJ; Vaiyapuri S; Stainer AR; Fry MJ; Gibbins JM
Arterioscler Thromb Vasc Biol; 2015 Nov; 35(11):2326-35. PubMed ID: 26359510
[TBL] [Abstract][Full Text] [Related]
5. cAMP- and cGMP-elevating agents inhibit GPIbα-mediated aggregation but not GPIbα-stimulated Syk activation in human platelets.
Makhoul S; Trabold K; Gambaryan S; Tenzer S; Pillitteri D; Walter U; Jurk K
Cell Commun Signal; 2019 Sep; 17(1):122. PubMed ID: 31519182
[TBL] [Abstract][Full Text] [Related]
6. Optimizing Platelet GPVI Inhibition versus Haemostatic Impairment by the Btk Inhibitors Ibrutinib, Acalabrutinib, ONO/GS-4059, BGB-3111 and Evobrutinib.
Denzinger V; Busygina K; Jamasbi J; Pekrul I; Spannagl M; Weber C; Lorenz R; Siess W
Thromb Haemost; 2019 Mar; 119(3):397-406. PubMed ID: 30685871
[TBL] [Abstract][Full Text] [Related]
7. Facilitating roles of murine platelet glycoprotein Ib and alphaIIbbeta3 in phosphatidylserine exposure during vWF-collagen-induced thrombus formation.
Kuijpers MJ; Schulte V; Oury C; Lindhout T; Broers J; Hoylaerts MF; Nieswandt B; Heemskerk JW
J Physiol; 2004 Jul; 558(Pt 2):403-15. PubMed ID: 15155790
[TBL] [Abstract][Full Text] [Related]
8. The role of Rac1 in glycoprotein Ib-IX-mediated signal transduction and integrin activation.
Delaney MK; Liu J; Zheng Y; Berndt MC; Du X
Arterioscler Thromb Vasc Biol; 2012 Nov; 32(11):2761-8. PubMed ID: 22995516
[TBL] [Abstract][Full Text] [Related]
9. Shear-induced interaction of platelets with von Willebrand factor results in glycoprotein Ibalpha shedding.
Cheng H; Yan R; Li S; Yuan Y; Liu J; Ruan C; Dai K
Am J Physiol Heart Circ Physiol; 2009 Dec; 297(6):H2128-35. PubMed ID: 19820200
[TBL] [Abstract][Full Text] [Related]
10. Oral administration of Bruton's tyrosine kinase inhibitors impairs GPVI-mediated platelet function.
Rigg RA; Aslan JE; Healy LD; Wallisch M; Thierheimer ML; Loren CP; Pang J; Hinds MT; Gruber A; McCarty OJ
Am J Physiol Cell Physiol; 2016 Mar; 310(5):C373-80. PubMed ID: 26659727
[TBL] [Abstract][Full Text] [Related]
11. Platelet physiology and thrombosis.
Andrews RK; Berndt MC
Thromb Res; 2004; 114(5-6):447-53. PubMed ID: 15507277
[TBL] [Abstract][Full Text] [Related]
12. A CD9, alphaIIbbeta3, integrin-associated protein, and GPIb/V/IX complex on the surface of human platelets is influenced by alphaIIbbeta3 conformational states.
Longhurst CM; White MM; Wilkinson DA; Jennings LK
Eur J Biochem; 1999 Jul; 263(1):104-11. PubMed ID: 10429193
[TBL] [Abstract][Full Text] [Related]
13. Evidence for a role of ADAM17 (TACE) in the regulation of platelet glycoprotein V.
Rabie T; Strehl A; Ludwig A; Nieswandt B
J Biol Chem; 2005 Apr; 280(15):14462-8. PubMed ID: 15691827
[TBL] [Abstract][Full Text] [Related]
14. Sequential activation of p38 and ERK pathways by cGMP-dependent protein kinase leading to activation of the platelet integrin alphaIIb beta3.
Li Z; Zhang G; Feil R; Han J; Du X
Blood; 2006 Feb; 107(3):965-72. PubMed ID: 16210341
[TBL] [Abstract][Full Text] [Related]
15. Glycoprotein IIb-IIIa-dependent aggregation by glycoprotein Ibalpha is reinforced by a Src family kinase inhibitor (PP1)-sensitive signalling pathway.
Marshall SJ; Asazuma N; Best D; Wonerow P; Salmon G; Andrews RK; Watson SP
Biochem J; 2002 Jan; 361(Pt 2):297-305. PubMed ID: 11772401
[TBL] [Abstract][Full Text] [Related]
16. Platelet endothelial cell adhesion molecule-1 inhibits platelet response to thrombin and von Willebrand factor by regulating the internalization of glycoprotein Ib via AKT/glycogen synthase kinase-3/dynamin and integrin αIIbβ3.
Jones CI; Sage T; Moraes LA; Vaiyapuri S; Hussain U; Tucker KL; Barrett NE; Gibbins JM
Arterioscler Thromb Vasc Biol; 2014 Sep; 34(9):1968-76. PubMed ID: 24969778
[TBL] [Abstract][Full Text] [Related]
17. The impacts of zanubrutinib on immune cells in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma.
Zou YX; Zhu HY; Li XT; Xia Y; Miao KR; Zhao SS; Wu YJ; Wang L; Xu W; Li JY
Hematol Oncol; 2019 Oct; 37(4):392-400. PubMed ID: 31420873
[TBL] [Abstract][Full Text] [Related]
18. Aspirin induces platelet receptor shedding via ADAM17 (TACE).
Aktas B; Pozgajova M; Bergmeier W; Sunnarborg S; Offermanns S; Lee D; Wagner DD; Nieswandt B
J Biol Chem; 2005 Dec; 280(48):39716-22. PubMed ID: 16179345
[TBL] [Abstract][Full Text] [Related]
19. Tumor necrosis factor-alpha-converting enzyme (ADAM17) mediates GPIbalpha shedding from platelets in vitro and in vivo.
Bergmeier W; Piffath CL; Cheng G; Dole VS; Zhang Y; von Andrian UH; Wagner DD
Circ Res; 2004 Oct; 95(7):677-83. PubMed ID: 15345652
[TBL] [Abstract][Full Text] [Related]
20. Zanubrutinib (BGB-3111), a Second-Generation Selective Covalent Inhibitor of Bruton's Tyrosine Kinase and Its Utility in Treating Chronic Lymphocytic Leukemia.
Rhodes JM; Mato AR
Drug Des Devel Ther; 2021; 15():919-926. PubMed ID: 33688166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
